PEPID Pulse: GLP-1 Receptor Agonist Overdose, Rising Toxicity Risks from Dosing Errors and Compounded Products & Baxdrostat (Baxfendy), First-in-Class Aldosterone Synthase Inhibitor for Uncontrolled Hypertension
Preview text: Don't miss out on what's new, stay updated once a month with the latest & greatest in…
No image available for this email.
- Subject
- PEPID Pulse: GLP-1 Receptor Agonist Overdose, Rising Toxicity Risks from Dosing Errors and Compounded Products & Baxdrostat (Baxfendy), First-in-Class Aldosterone Synthase Inhibitor for Uncontrolled Hypertension
- Preview text
- Don't miss out on what's new, stay updated once a month with the latest & greatest in…
- From
- marketing@
pepid.org - Brand
- PEPID
- Sent
- Wed Jun 17, 2026, 3:05 AM ET
- Size
- 82 KB
- Images
- 15
- Links
- 24, 5 of them buttons
- Subject length
- 213 characters
Against PEPID's usual
Sent in its busiest hour, 3 AM, which holds 33% of its emails. The subject is 213 characters; its average is 55.
Email headers
What the brand's servers put on this email. Our receiving servers, the address we subscribed with and unsubscribe links are left out.
- From
- PEPID <[email protected]>
- Subject
- PEPID Pulse: GLP-1 Receptor Agonist Overdose, Rising Toxicity Risks from Dosing Errors and Compounded Products & Baxdrostat (Baxfendy), First-in-Class Aldosterone Synthase Inhibitor for Uncontrolled Hypertension
- Date
- Wed, 17 Jun 2026 07:05:35 +0000 (GMT)
- Message-ID domain
- service-9
- Return-Path domain
- em-777810.pepid.org
- DKIM signature
- d=pepid.org s=acdkim1; d=acems3.com s=acdkim1
- List-Unsubscribe
- Present, one-click
- Mailer
- ActiveCampaign Mailer
- Feedback-ID sender
- activecampaign
Servers it passed through, newest first
- from s5.csa2.acemsd2.com [52.128.40.88] by our receiving server with ESMTPS
- from (unnamed) by acems1.com with ESMTPS
Other sending headers (names only): X-KumoRef, X-DKIM-Options, X-Virtual-Mta, X-250ok-CID, x-schedule, X-Sending-Engine, X-Report-Abuse, X-lid, X-mid
Sent just before and after
| Jun 24, 2026 8:06 AM | Before deal week ends — here's what EM Complete actually includes | |
| Jun 23, 2026 7:08 AM | The Deal Worth Buying This Week: $50 Off EM Complete! | |
| Jun 22, 2026 11:07 AM | EM Complete is $50 off — Priority Access Sale is live | |
| Jun 17, 2026 3:05 AM | PEPID Pulse: GLP-1 Receptor Agonist Overdose, Rising Toxicity Risks from Dosing Errors and Compounded Products & Baxdrostat (Baxfendy), First-in-Class Aldosterone Synthase Inhibitor for Uncontrolled Hypertension (this email) | |
| May 29, 2026 3:04 AM | 48 hours left — PEPID Memorial Day Sale ends May 31 | |
| May 26, 2026 3:04 AM | Only 7 days left to get any PEPID suite for $199.95 | |
| May 21, 2026 12:01 PM | For All Practicing Physicians: Here's What $199.95 Gets You |
More from PEPID
All PEPID emailsDon't forget to use your SAVE25 Promo!
Oct 12, 2026 12:07 PM
From ACEP26 to your next shift
Oct 12, 2026 3:00 AM
Oct 11, 2026 12:07 PM
You've just unlocked $25 off PEPID!
Oct 9, 2026 12:07 PM
Meet a few of our ACEP26 PEPID PAL winners!
Oct 6, 2026 6:35 PM
Missed ACEP26? You can still save $50
Oct 6, 2026 10:17 AM
Meet a few of our ACEP26 PEPID PAL winners!
Oct 5, 2026 7:25 PM
Booth #3225: Enter to win a PEPID PAL
Oct 3, 2026 11:15 AM







